Your browser doesn't support javascript.
loading
Correction to: RE­MIND2: comparative effectiveness of tafasitamab plus lenalidomide versus polatuzumab vedotin/bendamustine/rituximab (pola­BR), CAR­T therapies, and lenalidomide/rituximab (R2) based on real­world data in patients with relapsed/refractory diffuse large B­cell lymphoma.
Nowakowski, Grzegorz S; Yoon, Dok Hyun; Mondello, Patrizia; Joffe, Erel; Peters, Anthea; Fleury, Isabelle; Greil, Richard; Ku, Matthew; Marks, Reinhard; Kim, Kibum; Zinzani, Pier Luigi; Trotman, Judith; Sabatelli, Lorenzo; Waltl, Eva E; Winderlich, Mark; Sporchia, Andrea; Kurukulasuriya, Nuwan C; Cordoba, Raul; Hess, Georg; Salles, Gilles.
  • Nowakowski GS; Division of Hematology, Mayo Clinic, Rochester, MN, USA. Nowakowski.Grzegorz@mayo.edu.
  • Yoon DH; Department of Oncology, Asan Medical Center, Songpa­gu, Seoul, South Korea.
  • Mondello P; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
  • Joffe E; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
  • Peters A; Department of Oncology, University of Alberta, Edmonton, AB, Canada.
  • Fleury I; Maisonneuve­Rosemont Hospital, Institute of Hematology, Oncology and Cell Therapy, Montreal University, Montreal, Canada.
  • Greil R; Paracelsus Medical University Salzburg, Salzburg Cancer Research Institute-CCCIT, and Cancer Cluster Salzburg, Salzburg, Austria.
  • Ku M; Department of Haematology, St Vincent's Hospital and University of Melbourne, Melbourne, VIC, Australia.
  • Marks R; University Hospital Freiburg Internal Medicine I, Freiburg im Breisgau, Germany.
  • Kim K; University of Utah, Salt Lake City, UT, USA.
  • Zinzani PL; University of Illinois at Chicago, Chicago, IL, USA.
  • Trotman J; IRCCS Azienda Ospedaliero­Universitaria di Bologna, Istituto Di Ematologia "Seragnoli", Bologna, Italy.
  • Sabatelli L; Dipartimento Di Medicina Specialistica, Diagnostica E Sperimentale, Universita Di Bologna, Bologna, Italy.
  • Waltl EE; Haematology Department, Concord Repatriation General Hospital, University of Sydney, Concord, NSW, Australia.
  • Winderlich M; Incyte Biosciences International Sarl, Morges, Switzerland.
  • Sporchia A; MorphoSys AG, Planegg, Germany.
  • Kurukulasuriya NC; MorphoSys AG, Planegg, Germany.
  • Cordoba R; MorphoSys AG, Planegg, Germany.
  • Hess G; MorphoSys AG, Boston, MA, USA.
  • Salles G; Department of Hematology, Fundacion Jimenez Diaz University Hospital, Health Research Institute IISFJD, Madrid, Spain.
Ann Hematol ; 102(9): 2643-2644, 2023 Sep.
Article en En | MEDLINE | ID: mdl-37432417
Texto completo
Imprimir
XML
PubMed Links
Search on Google

Texto completo: 1 Banco de datos: MEDLINE Idioma: En Año: 2023 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Search on Google

Texto completo: 1 Banco de datos: MEDLINE Idioma: En Año: 2023 Tipo del documento: Article